TARSUS PHARMACEUTICALS, INC.: cash_and_equivalents
| Value | {"amount": 176210000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2024-09-30) |
| Status | current |
| Entity | TARSUS PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:18:23.133294+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/a3a8dc59-c981-4521-8142-40e6cf2a0464
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001819790-24-000129Retrieved: 2026-08-19T18:18:23.133294+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001819790/cash-and-equivalents/2024-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/a3a8dc59-c981-4521-8142-40e6cf2a0464
History
- no predecessors — first report